Cargando…
Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach
Kawasaki disease (KD) typically occurs in children aged under 5 years and can cause coronary artery lesions (CALs). Early diagnosis and treatment with intravenous immunoglobulin can reduce the occurrence of CALs; therefore, identifying a good biomarker for diagnosing KD is essential. Here, using nex...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929010/ https://www.ncbi.nlm.nih.gov/pubmed/34202375 http://dx.doi.org/10.3390/cimb43020037 |
_version_ | 1784670764073484288 |
---|---|
author | Weng, Ken-Pen Cheng, Ching-Feng Chien, Kuang-Jen Ger, Luo-Ping Huang, Shih-Hui Tsai, Kuo-Wang |
author_facet | Weng, Ken-Pen Cheng, Ching-Feng Chien, Kuang-Jen Ger, Luo-Ping Huang, Shih-Hui Tsai, Kuo-Wang |
author_sort | Weng, Ken-Pen |
collection | PubMed |
description | Kawasaki disease (KD) typically occurs in children aged under 5 years and can cause coronary artery lesions (CALs). Early diagnosis and treatment with intravenous immunoglobulin can reduce the occurrence of CALs; therefore, identifying a good biomarker for diagnosing KD is essential. Here, using next-generation sequencing in patients with recurrent KD, those with viral infection, and healthy controls, we identified dysregulated circulating microRNAs as diagnostic biomarkers for KD. Pathway enrichment analysis illustrated the putative role of these miRNAs in KD progression. Their expression levels were validated using real-time polymerase chain reaction (qPCR). Fifteen dysregulated circulating miRNAs (fold changes >2 and <0.5) were differentially expressed in the recurrent KD group compared with the viral infection and control groups. These miRNAs were significantly involved in the transforming growth factor-β, epithelial–mesenchymal transition, and cell apoptosis signaling pathways. Notably, their expression levels were frequently restored after intravenous immunoglobulin treatment. Among the candidates, miR-24-3p expression level was significantly higher in patients with recurrent KD compared with healthy controls or viral infection controls (p < 0.001). Receiver operating characteristic analysis revealed that high miR-24-3p expression levels may be a potential biomarker for KD diagnosis. In conclusion, we identified miR-24-3p significantly higher in KD patients, which may be a potential diagnostic biomarker for KD. |
format | Online Article Text |
id | pubmed-8929010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89290102022-06-04 Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach Weng, Ken-Pen Cheng, Ching-Feng Chien, Kuang-Jen Ger, Luo-Ping Huang, Shih-Hui Tsai, Kuo-Wang Curr Issues Mol Biol Article Kawasaki disease (KD) typically occurs in children aged under 5 years and can cause coronary artery lesions (CALs). Early diagnosis and treatment with intravenous immunoglobulin can reduce the occurrence of CALs; therefore, identifying a good biomarker for diagnosing KD is essential. Here, using next-generation sequencing in patients with recurrent KD, those with viral infection, and healthy controls, we identified dysregulated circulating microRNAs as diagnostic biomarkers for KD. Pathway enrichment analysis illustrated the putative role of these miRNAs in KD progression. Their expression levels were validated using real-time polymerase chain reaction (qPCR). Fifteen dysregulated circulating miRNAs (fold changes >2 and <0.5) were differentially expressed in the recurrent KD group compared with the viral infection and control groups. These miRNAs were significantly involved in the transforming growth factor-β, epithelial–mesenchymal transition, and cell apoptosis signaling pathways. Notably, their expression levels were frequently restored after intravenous immunoglobulin treatment. Among the candidates, miR-24-3p expression level was significantly higher in patients with recurrent KD compared with healthy controls or viral infection controls (p < 0.001). Receiver operating characteristic analysis revealed that high miR-24-3p expression levels may be a potential biomarker for KD diagnosis. In conclusion, we identified miR-24-3p significantly higher in KD patients, which may be a potential diagnostic biomarker for KD. MDPI 2021-06-25 /pmc/articles/PMC8929010/ /pubmed/34202375 http://dx.doi.org/10.3390/cimb43020037 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Weng, Ken-Pen Cheng, Ching-Feng Chien, Kuang-Jen Ger, Luo-Ping Huang, Shih-Hui Tsai, Kuo-Wang Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach |
title | Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach |
title_full | Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach |
title_fullStr | Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach |
title_full_unstemmed | Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach |
title_short | Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach |
title_sort | identifying circulating microrna in kawasaki disease by next-generation sequencing approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929010/ https://www.ncbi.nlm.nih.gov/pubmed/34202375 http://dx.doi.org/10.3390/cimb43020037 |
work_keys_str_mv | AT wengkenpen identifyingcirculatingmicrornainkawasakidiseasebynextgenerationsequencingapproach AT chengchingfeng identifyingcirculatingmicrornainkawasakidiseasebynextgenerationsequencingapproach AT chienkuangjen identifyingcirculatingmicrornainkawasakidiseasebynextgenerationsequencingapproach AT gerluoping identifyingcirculatingmicrornainkawasakidiseasebynextgenerationsequencingapproach AT huangshihhui identifyingcirculatingmicrornainkawasakidiseasebynextgenerationsequencingapproach AT tsaikuowang identifyingcirculatingmicrornainkawasakidiseasebynextgenerationsequencingapproach |